Ranbaxy, Pfizer Sued In U.S. For Delaying Lipitor Generic 20 Months
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories and Pfizer have been sued by some of the largest drug stores in the U.S. for their "anti-competitive" marketing arrangement for the blockbuster Lipitor (atorvastatin) for treating cholesterol.